CEBP Frontiers in Cancer Prevention Research - 2008 Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trevisan, M.
Right arrow Articles by Fucci, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trevisan, M.
Right arrow Articles by Fucci, F.
Cancer Epidemiology Biomarkers & Prevention Vol. 10, 937-941, September 2001
© 2001 American Association for Cancer Research

Markers of Insulin Resistance and Colorectal Cancer Mortality

Maurizio Trevisan1, Jian Liu, Paola Muti, Giovanni Misciagna, Alessandro Menotti, Federica Fucci and on behalf of the Risk Factors and Life Expectancy Research Group

Department of Social and Preventive Medicine, State University of New York at Buffalo, School of Medicine and Biomedical Sciences, Buffalo, New York, [M. T., J. L., P. M., G. M., F. F.] 14214, and Cardioricerca, 00198 Rome, Italy [A. M.]

A link between insulin metabolism and colorectal cancer has been hypothesized, supported by a series of potential physiological mechanisms, and confirmed by a number of reports in experimental animals. However, the evidence in humans is limited and mostly indirect.

The aim of the present report is to analyze whether individuals with a cluster of metabolic abnormalities associated with abnormalities in insulin metabolism experience higher mortality for colorectal cancer than those without this cluster of metabolic abnormalities.

A total of 21,311 men and 15,991 women 20–69 years of age were followed-up for an average of 7 years as part of the Risk Factors and Life Expectancy Project, a pooling of a number of epidemiological studies conducted in Italy.

Our analyses indicate that participants with high levels of blood glucose and a cluster of metabolic abnormalities linked to insulin resistance experienced a significant increased risk of colorectal cancer mortality compared with participants without the cluster. For the presence of the cluster of metabolic abnormalities, the calculated hazard ratios and 95% CIs were 2.96 (1.05–8.31) for men, 2.71 (0.59–12.50) for women, and 2.99 (1.27–7.01) when both sexes were combined. These associations were independent from the potential confounding effect of age, drinking of alcoholic beverages, and smoking.

Our findings are supportive of the hypotheses that glucose metabolism hyperinsulinemia, insulin resistance, and metabolic abnormalities associated with it may play a significant role in the etiology of colorectal cancer.




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
E. Giovannucci
Metabolic syndrome, hyperinsulinemia, and colon cancer: a review
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 836S - 842S.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. L. Ahmed, W. Thomas, and K. H. Schmitz
Interactions between Insulin, Body Fat, and Insulin-Like Growth Factor Axis Proteins
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 593 - 597.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
T. Sturmer, J. E. Buring, I-M. Lee, J. M. Gaziano, and R. J. Glynn
Metabolic Abnormalities and Risk for Colorectal Cancer in the Physicians' Health Study
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2391 - 2397.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Flood, U. Peters, D. J. Jenkins, N. Chatterjee, A. F Subar, T. R Church, R. Bresalier, J. L Weissfeld, R. B Hayes, A. Schatzkin, et al.
Carbohydrate, glycemic index, and glycemic load and colorectal adenomas in the Prostate, Lung, Colorectal, and Ovarian Screening Study.
Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1184 - 1192.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Cowey and R. W. Hardy
The Metabolic Syndrome: A High-Risk State for Cancer?
Am. J. Pathol., November 1, 2006; 169(5): 1505 - 1522.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
K. Bowers, D. Albanes, P. Limburg, P. Pietinen, P. R. Taylor, J. Virtamo, and R. Stolzenberg-Solomon
A Prospective Study of Anthropometric and Clinical Measurements Associated with Insulin Resistance Syndrome and Colorectal Cancer in Male Smokers
Am. J. Epidemiol., October 1, 2006; 164(7): 652 - 664.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Lin, P. M. Ridker, A. Pradhan, I-M. Lee, J. E. Manson, N. R. Cook, J. E. Buring, and S. M. Zhang
Hemoglobin A1c Concentrations and Risk of Colorectal Cancer in Women
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 3010 - 3012.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Oh, W. C. Willett, C. S. Fuchs, and E. L. Giovannucci
Glycemic Index, Glycemic Load, and Carbohydrate Intake in Relation to Risk of Distal Colorectal Adenoma in Women
Cancer Epidemiol. Biomarkers Prev., July 1, 2004; 13(7): 1192 - 1198.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K.-T. Khaw, N. Wareham, S. Bingham, R. Luben, A. Welch, and N. Day
Preliminary Communication: Glycated Hemoglobin, Diabetes, and Incident Colorectal Cancer in Men and Women: A Prospective Analysis from the European Prospective Investigation into Cancer-Norfolk Study
Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 915 - 919.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. Ma, E. Giovannucci, M. Pollak, A. Leavitt, Y. Tao, J. M. Gaziano, and M. J. Stampfer
A Prospective Study of Plasma C-Peptide and Colorectal Cancer Risk in Men
J Natl Cancer Inst, April 7, 2004; 96(7): 546 - 553.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
D. B. Boyd
Insulin and Cancer
Integr Cancer Ther, December 1, 2003; 2(4): 315 - 329.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. H. Saydah, E. A. Platz, N. Rifai, M. N. Pollak, F. L. Brancati, and K. J. Helzlsouer
Association of Markers of Insulin and Glucose Control with Subsequent Colorectal Cancer Risk
Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 412 - 418.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
D. Komninou, A. Ayonote, J. P. Richie Jr., and B. Rigas
Insulin Resistance and Its Contribution to Colon Carcinogenesis
Experimental Biology and Medicine, April 1, 2003; 228(4): 396 - 405.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
T. T. Tran, N. Gupta, T. Goh, D. Naigamwalla, M. C. Chia, N. Koohestani, S. Mehrotra, G. McKeown-Eyssen, A. Giacca, and W. R. Bruce
Direct Measure of Insulin Sensitivity with the Hyperinsulinemic-Euglycemic Clamp and Surrogate Measures of Insulin Sensitivity with the Oral Glucose Tolerance Test: Correlations with Aberrant Crypt Foci Promotion in Rats
Cancer Epidemiol. Biomarkers Prev., January 1, 2003; 12(1): 47 - 56.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.